chr7-103989356-T-TGCCGCCGCCGCCGCCGCCGCC
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_005045.4(RELN):c.-21_-1dupGGCGGCGGCGGCGGCGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0041 ( 6 hom., cov: 0)
Exomes 𝑓: 0.0012 ( 32 hom. )
Failed GnomAD Quality Control
Consequence
RELN
NM_005045.4 5_prime_UTR
NM_005045.4 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.06
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00407 (604/148366) while in subpopulation EAS AF= 0.0292 (137/4696). AF 95% confidence interval is 0.0252. There are 6 homozygotes in gnomad4. There are 295 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RELN | NM_005045.4 | c.-21_-1dupGGCGGCGGCGGCGGCGGCGGC | 5_prime_UTR_variant | 1/65 | ENST00000428762.6 | NP_005036.2 | ||
RELN | NM_173054.3 | c.-21_-1dupGGCGGCGGCGGCGGCGGCGGC | 5_prime_UTR_variant | 1/64 | NP_774959.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RELN | ENST00000428762.6 | c.-21_-1dupGGCGGCGGCGGCGGCGGCGGC | 5_prime_UTR_variant | 1/65 | 5 | NM_005045.4 | ENSP00000392423.1 |
Frequencies
GnomAD3 genomes AF: 0.00405 AC: 601AN: 148268Hom.: 6 Cov.: 0
GnomAD3 genomes
AF:
AC:
601
AN:
148268
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00118 AC: 1487AN: 1259304Hom.: 32 Cov.: 36 AF XY: 0.00111 AC XY: 688AN XY: 620268
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1487
AN:
1259304
Hom.:
Cov.:
36
AF XY:
AC XY:
688
AN XY:
620268
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00407 AC: 604AN: 148366Hom.: 6 Cov.: 0 AF XY: 0.00408 AC XY: 295AN XY: 72352
GnomAD4 genome
AF:
AC:
604
AN:
148366
Hom.:
Cov.:
0
AF XY:
AC XY:
295
AN XY:
72352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 12, 2016 | - - |
Lissencephaly, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
RELN-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 24, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at